“Findings: In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata. The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged 12 to 15 years (70.7 per million doses of the BNT162b2 vaccine), in adolescent males aged 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine), and in young men aged 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively).
Meaning: Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.”
Authors who wish to publish open access research articles in JAMA Network journals will be offered a Creative Commons (CC) license in exchange for payment of an article processing charge. The CC licenses, often required by funders, allow authors to retain copyright of their research articles. An open access article is free for everyone to read immediately and can be distributed without permission, provided that appropriate credit is given. Information provided by the author during the submission process will determine the appropriate CC license. Most authors will receive a CC-BY license, which offers the broadest reuse rights. Authors who report a commercial funding source will receive a CC-BY-NC-ND license.